Exa-Cel Sustains Promising Efficacy as SCD Treatment in Phase III Trial
What Are the Risk Factors for Pain Crisis in Patients With SCD After HSCT?
Fidanacogene Elaparvovec-dzkt Approved by FDA for Hemophilia B